{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:22:30Z","timestamp":1792664550382,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I21RX003722"],"award-info":[{"award-number":["I21RX003722"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX002823"],"award-info":[{"award-number":["I01BX002823"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuroscience.2025.12.057","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:18:10Z","timestamp":1766506690000},"page":"190-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Acute administration of a dual orexin receptor antagonist attenuates sleep fragmentation in a mouse model of traumatic brain injury"],"prefix":"10.1016","volume":"594","author":[{"given":"Sean D.","family":"Carey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hryhoriy","family":"Zhoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0504-1250","authenticated-orcid":false,"given":"Jessica A.","family":"Babb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary B.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.12.057_b0005","unstructured":"America BIAo. Brain Injury Severity 2024 [Available from: https:\/\/www.biausa.org\/brain-injury\/about-brain-injury\/diagnosis\/injury-severity."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/NSS.S182158","article-title":"Impact of traumatic brain injury on sleep: an overview","volume":"11","author":"Aoun","year":"2019","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105053","article-title":"Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant","volume":"127","author":"Asakura","year":"2021","journal-title":"Regul. Toxicol. Pharm."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12974-015-0289-5","article-title":"Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic","volume":"12","author":"Bachstetter","year":"2015","journal-title":"J. Neuroinflam."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/01.wnl.0000167605.02541.f2","article-title":"Hypocretin-1 (orexin a) deficiency in acute traumatic brain injury","volume":"65","author":"Baumann","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.057_b0030","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","article-title":"Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia","volume":"37","author":"Bettica","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.057_b0035","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz076","article-title":"Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep\/wake regulation","volume":"42","author":"Beuckmann","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1040975","article-title":"Dexmedetomidine-mediated sleep phase modulation ameliorates motor and cognitive performance in a chronic blast-injured mouse model","volume":"13","author":"Bibineyshvili","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0045","doi-asserted-by":"crossref","unstructured":"Brasure M, Lamberty GJ, Sayer NA, Nelson NW, MacDonald R, Ouellette J, et al. Multidisciplinary postacute rehabilitation for moderate to severe traumatic brain injury in adults [internet]. 2012.","DOI":"10.1016\/j.apmr.2012.12.019"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.057_b0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5664\/jcsm.26855","article-title":"Prevalence and consequences of sleep disorders in traumatic brain injury","volume":"3","author":"Castriotta","year":"2007","journal-title":"J. Clin. Sleep Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.057_b0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5664\/jcsm.27442","article-title":"Treatment of sleep disorders after traumatic brain injury","volume":"5","author":"Castriotta","year":"2009","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0060","unstructured":"CDC. National Center for Health Statistics: Mortality data on CDC WONDER. 2025."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.057_b0065","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00325481.2022.2049553","article-title":"Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder","volume":"134","author":"Chepke","year":"2022","journal-title":"Postgrad. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: Hypothalamus-specific peptides with neuroexcitatory\u2009activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0075","unstructured":"DOD. 2000-2025 Q1 DOD Worldwide Numbers for TBI. 2025."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0080","series-title":"Neurocognitive Consequences of Sleep Deprivation. Seminars in Neurology","year":"2005"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.057_b0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/neurolint13040059","article-title":"Benzodiazepines: uses, dangers, and clinical considerations","volume":"13","author":"Edinoff","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00008","article-title":"Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep\/wakefulness states in mice","volume":"8","author":"Etori","year":"2014","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.057_b0095","article-title":"The dual orexinergic receptor antagonist DORA-22 improves the sleep disruption and memory impairment produced by a rodent insomnia model","volume":"43","author":"Gamble","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113946","article-title":"Contusion brain damage in mice for modelling of post-traumatic epilepsy with contralateral hippocampus sclerosis: Comprehensive and longitudinal characterization of spontaneous seizures, neuropathology, and neuropsychiatric comorbidities","volume":"348","author":"Golub","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1361014","article-title":"Sleep, inflammation, and hemodynamics in rodent models of traumatic brain injury","volume":"18","author":"Green","year":"2024","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.057_b0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with Insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"08","key":"10.1016\/j.neuroscience.2025.12.057_b0115","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.5664\/jcsm.7282","article-title":"An update on dual orexin receptor antagonists and their potential role in insomnia therapeutics","volume":"14","author":"Janto","year":"2018","journal-title":"J. Clin. Sleep Med."},{"issue":"19","key":"10.1016\/j.neuroscience.2025.12.057_b0120","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/neu.2017.5291","article-title":"Contribution of fibrinogen to inflammation and neuronal density in human traumatic brain injury","volume":"35","author":"Jenkins","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.057_b0125","article-title":"Night-to-night variability in sleep and amyloid beta burden in normal aging","volume":"15","author":"Jouvencel","year":"2023","journal-title":"Alzheimer's Dement. Diagn. Assess. Dis. Monitor."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2020.05.025","article-title":"Lemborexant vs suvorexant for insomnia: a systematic review and network meta-analysis","volume":"128","author":"Kishi","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41398-024-03087-4","article-title":"Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review","volume":"14","author":"Kishi","year":"2024","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.057_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsac238","article-title":"Dual orexin antagonist normalized sleep homeostatic drive, enhanced GABAergic inhibition, and suppressed seizures after traumatic brain injury","volume":"45","author":"Konduru","year":"2022","journal-title":"Sleep"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110961","article-title":"Expression of orexin-a (hypocretin-a) in the hypothalamus after traumatic brain injury: a postmortem evaluation","volume":"327","author":"Kousi","year":"2021","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41386-019-0474-9","article-title":"Sleep therapeutics and neuropsychiatric illness","volume":"45","author":"Krystal","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0155","series-title":"Translational Research in Traumatic Brain Injury","author":"Laskowitz","year":"2016"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.057_b0160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3171\/jns.1987.66.5.0706","article-title":"Magnetic resonance imaging and computerized tomography in relation to the neurobehavioral sequelae of mild and moderate head injuries","volume":"66","author":"Levin","year":"1987","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neubiorev.2015.04.010","article-title":"Sleep disruption and the sequelae associated with traumatic brain injury","volume":"55","author":"Lucke-Wold","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.057_b0170","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz302","article-title":"Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice","volume":"43","author":"Mahoney","year":"2019","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NSS.S134864","article-title":"Short- and long-term health consequences of sleep disruption","volume":"9","author":"Medic","year":"2017","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0185","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neulet.2017.05.054","article-title":"Chronic sleep fragmentation exacerbates amyloid \u03b2 deposition in Alzheimer\u2019s disease model mice","volume":"653","author":"Minakawa","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14283\/jpad.2020.69","article-title":"Safety and efficacy of lemborexant in patients with irregular sleep-wake rhythm disorder and Alzheimer\u2019s disease dementia: results from a phase 2 randomized clinical trial","volume":"8","author":"Moline","year":"2021","journal-title":"J. Prev Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.057_b0195","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/ajp.155.7.929","article-title":"Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans","volume":"155","author":"Neylan","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/neu.2017.5067","article-title":"Increased sleep need and Reduction of Tuberomammillary Histamine Neurons after Rodent Traumatic Brain Injury","volume":"35","author":"Noain","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"S02","key":"10.1016\/j.neuroscience.2025.12.057_b0210","first-page":"111","article-title":"Sleep fragmentation and working memory in healthy adults","volume":"14","author":"Okuda","year":"2021","journal-title":"Sleep Sci"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.057_b0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/HTR.0b013e3181a0b281","article-title":"Traumatic brain injury and sleep disturbance: a review of current research","volume":"24","author":"Orff","year":"2009","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0220","article-title":"The controlled cortical impact model: applications, considerations for researchers, and future directions","volume":"7\u20132016","author":"Osier","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0225","series-title":"Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2019"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.12.057_b0230","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1177\/02692155211014827","article-title":"Treatments for sleep disturbances in individuals with acquired brain injury: a systematic review","volume":"35","author":"Pilon","year":"2021","journal-title":"Clin. Rehabil."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.057_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add1101","article-title":"Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration","volume":"9","author":"Ritzel","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0240","article-title":"Controlled cortical impact model for traumatic brain injury","volume":"90","author":"Romine","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.12.057_b0245","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1089\/neu.2006.23.1241","article-title":"Differential behavioral and histopathological responses to graded cortical impact injury in mice","volume":"23","author":"Saatman","year":"2006","journal-title":"J. Neurotrauma"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.12.057_b0250","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrn3837","article-title":"The role of orexin in motivated behaviours","volume":"15","author":"Sakurai","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.057_b0255","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.057_b0260","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/sleep\/33.12.1615","article-title":"Sleep patterns before, during, and after deployment to Iraq and Afghanistan","volume":"33","author":"Seelig","year":"2010","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.057_b0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/neu.2014.3664","article-title":"Chronic decrease in wakefulness and disruption of sleep-wake behavior after experimental traumatic brain injury","volume":"32","author":"Skopin","year":"2015","journal-title":"J. Neurotrauma"},{"issue":"19\u201320","key":"10.1016\/j.neuroscience.2025.12.057_b0270","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1089\/neu.2023.0125","article-title":"Mild traumatic brain injury affects orexin\/hypocretin physiology differently in male and female mice","volume":"40","author":"Somach","year":"2023","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0275","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1089\/neur.2024.0111","article-title":"Effects of traumatic brain injury on the orexin\/hypocretin system","volume":"6","author":"Somach","year":"2025","journal-title":"Neurotrauma Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/sleep\/7.1.18","article-title":"Sleep fragmentation and daytime sleepiness","volume":"7","author":"Stepanski","year":"1984","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10010148","article-title":"Assessing the Severity of Traumatic Brain Injury-Time for a Change?","volume":"10","author":"Tenovuo","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/jnp.13.1.77","article-title":"An EEG severity index of traumatic brain injury","volume":"13","author":"Thatcher","year":"2001","journal-title":"J. Neuropsych. Clin. Neurosci."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nbscr.2016.03.001","article-title":"Hypocretinergic and cholinergic contributions to sleep-wake disturbances in a mouse model of traumatic brain injury","volume":"2","author":"Thomasy","year":"2017","journal-title":"Neurobiol. Sleep Circad. Rhythms."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.057_b0300","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0474-23.2024","article-title":"Whole brain mapping of orexin receptor mRNA expression visualized by branched in situ hybridization chain reaction","volume":"11","author":"Tsuneoka","year":"2024","journal-title":"eNeuro."},{"key":"10.1016\/j.neuroscience.2025.12.057_b0305","article-title":"Performance of male and female C57BL\/6J mice on motor and cognitive tasks commonly used in pre-clinical traumatic brain injury research","volume":"33","author":"Tucker","year":"2015","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0310","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1742-2094-11-82","article-title":"Macrophagic and microglial responses after focal traumatic brain injury in the female rat","volume":"11","author":"Turtzo","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.057_b0315","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/sleep\/27.3.388","article-title":"Murine multiple sleep latency test: phenotyping sleep propensity in mice","volume":"27","author":"Veasey","year":"2004","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.057_b0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.26857","article-title":"Hypersomnia following traumatic brain injury","volume":"3","author":"Watson","year":"2007","journal-title":"J. Clin. Sleep Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.057_b0325","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45310","article-title":"Trajectories of insomnia in adults after traumatic brain injury","volume":"5","author":"Wickwire","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuroscience.2025.12.057_b0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbi.2017.01.012","article-title":"The NLRP3 inflammasome modulates sleep and NREM sleep delta power induced by spontaneous wakefulness, sleep deprivation and lipopolysaccharide","volume":"62","author":"Zielinski","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"Supplement_2","key":"10.1016\/j.neuroscience.2025.12.057_b0335","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1093\/sleep\/zsab072.006","article-title":"007 NLRP3 inflammasomes contribute to dysregulated sleep and electroencephalogram delta power after mild and moderate TBI in mice","volume":"44","author":"Zielinski","year":"2021","journal-title":"Sleep"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225012242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225012242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:26:14Z","timestamp":1768969574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225012242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":67,"alternative-id":["S0306452225012242"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.057","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute administration of a dual orexin receptor antagonist attenuates sleep fragmentation in a mouse model of traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}